Russian Federation
Federal State Budgetary Educational Institution of Higher Education “North-West State Medical University named after I.I. Mechnikov” (Department of Propaedeutics of Internal Medicine, Gastroenterology and Dietetics named after S.M. Ryss, Graduate student)
Russian Federation
This study is focused on efficiency of various rifaximin-α regimens in order to optimize the treatment and preventive approaches for cirrhosis of the liver with minimal hepatic encephalopathy, as well as to predict the course of the disease and the risk of complications.
cirrhosis of the liver, hepatic encephalopathy, treatment and preventive approaches for cirrhosis of the liver
1. Butterworth R.F. Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology // Drugs. – 2019, 79(1):17–21. Doi: 10.1007s40265-018-1017-0
2. Bakulin I.G., Ivanova K.N. Sovremennye podhody k diagnostike i lecheniyu minimal'noy pechenochnoy encefalopatii u pacientov s cirrozom pecheni // RMZh. Medicinskoe obozrenie. – 2022, 6(5):272-277. Doi:https://doi.org/10.32364/2587-6821-2022-6-5-272-277
3. Pisarek W. Minimal hepatic encephalopathy – diagnosis and treatment // Przeglad gastroenterologiczny. – 2021, 16(4):311-317. Doi:https://doi.org/10.5114/pg.2021.111389
4. Redfield R., Latt N., Munoz, S. J. Minimal Hepatic Encephalopathy // Clinics in liver disease. – 2024, 28(2): 237–252. doi.org/10.1016/j.cld.2024.01.004
5. Bakulin I.G. Sravnitel'naya effektivnost' razlichnyh rezhimov terapii rifaksiminom-α u pacientov s minimal'noy pechenochnoy encefalopatiey i cirrozom pecheni (analiz shestimesyachnogo nablyudeniya) / I.G. Bakulin, K.N. Ivanova, A.V. Abdrahmanov // Effektivnaya farmakoterapiya. – 2024. – T. 20, № 2. – S. 20–25. Doi:https://doi.org/10.33978/2307-3586- 2024-20-2-20-25
6. Bakulin I.G. Vliyanie razlichnyh rezhimov terapii rifaksimina-α na kliniko-laboratornye pokazateli u pacientov s minimal'noy pechenochnoy encefalopatiey i cirrozom pecheni v techenie 12 mesyacev nablyudeniya / I.G. Bakulin, K.N. Ivanova // Botkinskie chteniya: sbornik tezisov Vserossiyskogo terapevticheskogo kongressa s mezhdunarodnym uchastiem, Sankt-Peterburg, 18–19 aprelya 2024 goda. – Sankt-Peterburg: Sankt-Peterburgskaya obschestvennaya organizaciya «Chelovek i ego zdorov'e», 2024. – S. 26–27.
7. Miwa T., Hanai T., Toshihide M., Ogiso Y., Imai K., Suetsugu A., Takai K., Shiraki M., Katsumura N., Shimizu M.Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy // Hepatology research: the official journal of the Japan Society of Hepatology. – 2021, 51(6): 662–673. doi.org/10.1111/hepr.13601
8. Moran S., López-Sánchez M., Milke-García M.D.P., Rodríguez-Leal G. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis // World journal of gastroenterology. – 2021, 27(22): 3050–3063. doi.org/10.3748/wjg.v27.i22.3050
